Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA.
Authors: Asan et al.
Posted in Papers / Original Research / Human Studies / December 1-15, 2022
Share this article
Sign Up For An MSC Newsletter
Sign Up for MSC Content Alerts!
Receive immediate notification when a new piece of content is published on MSC! You can sign up for new article alerts, new literature recap alerts, and/or our monthly newsletter. Visit here to sign up.